Govt to Roll Out Twice-Yearly HIV Injection in Major Prevention Push
By Shalom Shawurwa Zimbabwe is preparing to place at least 46 500 people on a long-acting HIV prevention drug early next year marking the country’s first rollout of Lenacapavir a twice-yearly injectable that offers sustained protection against HIV. Health officials say the introduction of Lenacapavir